Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Tech Transfer Roundup: Athenex, PDS Align With National Cancer Institute On Oncology R&D

Nov 25 2021

• By Joseph Haas

Tech Transfer

Related Content

Antios Raises $96m To Advance HBV Drug With Pharmasset Pedigree

Apr 12 2021

BridgeBio, Helsinn Partner Again After Truseltiq Success

Nov 19 2021

Setback For Athenex, Hanmi As CRL Requests New Trial

Mar 04 2021

Related Companies

Athenex, Inc.

National Cancer Institute

Hanmi Pharmaceutical Co., Ltd.

PDS Biotechnology Corporation

University of Georgia Research Foundation

Antios Therapeutics Inc.

IRBM Science Park SpA

San Raffaele Hospital

Ocuphire Pharma

Harvard University

Massachusetts Eye & Ear Infirmary

University of Pennsylvania

Mustang Bio Inc.

Leiden University Medical Center

Boehringer Ingelheim GmbH

King's College London

Simcere Pharmaceutical Group

Shanghai Institute of Materia Medica

Abintus Bio, Inc.

Memorial Sloan Kettering Cancer Center

University of Pittsburgh

University of Wisconsin, Madison

Tessera Therapeutics

Cystic Fibrosis Foundation

Quoin Pharmaceuticals, Ltd.

Queensland University of Technology

CANbridge Pharmaceuticals Inc.

University of Washington

BridgeBio Pharma, Inc.

Columbia University

Icahn School of Medicine

Silo Pharma, Inc.

Evotec SE

Atreca, Inc.

SpringWorks Therapeutics Inc.

Dana-Farber/Harvard Cancer Center

Stanford University School of Medicine

CoImmune, Inc.

Titan Pharmaceuticals Inc.

Medical University of South Carolina

Additional Topics

Deals Business Strategies Research & Development Commercial Tech Transfer Round-Up BioPharmaceutical

More from Deals

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window